Design and Discovery of N-(2-Methyl-5'-morpholino-6'-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3'-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers.
J Med Chem
; 60(12): 4869-4881, 2017 06 22.
Article
in En
| MEDLINE
| ID: mdl-28557458
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzamides
/
2,2'-Dipyridyl
/
Ras Proteins
/
Raf Kinases
/
Antineoplastic Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
J Med Chem
Journal subject:
QUIMICA
Year:
2017
Type:
Article
Affiliation country:
United States